MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.596
EU - Europa 5.818
AS - Asia 2.189
Continente sconosciuto - Info sul continente non disponibili 72
SA - Sud America 21
OC - Oceania 9
AF - Africa 8
Totale 20.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.185
CN - Cina 1.802
PL - Polonia 1.483
IT - Italia 1.083
DE - Germania 935
UA - Ucraina 497
SE - Svezia 475
GB - Regno Unito 459
CA - Canada 400
FR - Francia 338
FI - Finlandia 225
SG - Singapore 201
IE - Irlanda 114
EU - Europa 71
BE - Belgio 68
CZ - Repubblica Ceca 36
VN - Vietnam 34
IN - India 30
RU - Federazione Russa 29
KR - Corea 27
TR - Turchia 24
RO - Romania 21
NL - Olanda 19
HK - Hong Kong 16
IR - Iran 16
BR - Brasile 9
MX - Messico 8
AU - Australia 7
JP - Giappone 7
AR - Argentina 6
AT - Austria 5
CH - Svizzera 5
ES - Italia 4
JO - Giordania 4
LB - Libano 4
PK - Pakistan 4
RS - Serbia 4
CL - Cile 3
DK - Danimarca 3
IL - Israele 3
NO - Norvegia 3
SA - Arabia Saudita 3
TW - Taiwan 3
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AS - Samoa Americane 1
CM - Camerun 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 20.713
Salva come PNG Salva come JPEG
Città #
Fairfield 1.500
Woodbridge 1.484
Jacksonville 1.203
Warsaw 1.148
Chandler 948
Houston 788
Ashburn 753
Ann Arbor 710
Wilmington 685
Seattle 627
Cambridge 545
Nanjing 404
Kraków 331
Toronto 280
Camerino 192
San Mateo 184
Boardman 173
Düsseldorf 169
Lawrence 163
Princeton 163
Beijing 158
Dearborn 155
Columbus 137
Ogden 137
Nanchang 125
Singapore 124
Lachine 116
Dublin 112
London 112
Shanghai 94
Helsinki 88
Kunming 86
Guangzhou 78
San Diego 75
Milan 71
Brussels 65
Shenyang 63
Hebei 61
Jiaxing 60
Tianjin 58
New York 54
Los Angeles 44
Chicago 43
Hangzhou 41
Wuhan 39
Centro 37
Venezia 36
Ningbo 35
Philadelphia 35
Changsha 33
Dong Ket 31
Hefei 30
Redwood City 30
Brno 26
Venice 26
Orange 25
Jinan 24
Norwalk 24
Bremen 23
Falls Church 23
Perugia 22
Nürnberg 21
Munich 20
Yiwu 20
Buffalo 18
Verona 18
Zhengzhou 18
Old Bridge 16
Auburn Hills 15
Scafati 15
Kocaeli 14
Lanzhou 14
Council Bluffs 13
San Francisco 13
Jinhua 12
New Bedfont 12
Shenzhen 12
Tappahannock 12
Tulsa 12
West Jordan 12
Changchun 11
Leawood 11
Horia 10
Bologna 9
Caserta 9
Hounslow 9
Mountain View 9
Scuola 9
Simi Valley 9
Taizhou 9
Ardabil 8
Buti 8
Indiana 8
Meppel 8
Münster 8
Naples 8
Rome 8
Sindelfingen 8
St Petersburg 8
Washington 8
Totale 15.568
Salva come PNG Salva come JPEG
Nome #
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 326
Overview on Radiolabel-Free in Vitro Assays for GPCRs 313
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 271
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 265
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 260
Pharmacological characterization of the GPR17 receptor dual profile 251
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 249
The G Protein-Coupled Receptor GPR17: Overview and Update 246
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 235
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 224
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 222
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 208
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 207
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 197
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 197
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 192
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 186
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 186
GPR17 receptor modulators and their therapeutic implications: review of recent patents 184
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 180
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 177
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 176
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 176
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 174
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 170
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 167
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 167
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 167
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 165
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 163
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 161
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 160
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 160
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 156
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 156
New sensible method to quantize the intestinal absorption of receptor ligands 155
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 154
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 154
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 153
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 153
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 153
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 152
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 152
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 149
null 149
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 149
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 149
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 148
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 148
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 147
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 147
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 146
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 145
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 145
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 145
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 145
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 145
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 144
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 144
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 143
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 143
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 142
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 142
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 142
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 142
Synthesis and pharmacological characterization of new chiral derivatives of muscarine and allo-muscarine 138
“Novel and Highly Selective Postsynaptic α-Adrenoreceptor Antagonists: Synthesis and Structure-Activity Relationships of Alkane-Bridged [4-(phenoxyethyl)-1-piperazinyl]-3 (2H)-pyridazinones”. 138
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 138
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 137
Structure-Activity Relationships of Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists. 2. Role of Polymethylene Chain Lengths Separating Amine Functions and of Substituents on the Terminal Nitrogen Atoms. 137
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 136
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 136
Antiviral properties of deazaadenine nucleoside derivatives 136
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 135
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 135
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 134
Adenosine receptor modeling: what does the A2A crystal structure tell us? 133
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 133
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 131
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 131
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 130
Polyamines may modulate both G protein-coupled receptors and G proteins. 129
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 127
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 126
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 126
SAR Studies on the Potent and Selective Muscarinic Antagonist 2-Ethylthio-2,2-diphenylacetic Acid N,N-Diethylaminoethyl Ester 126
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 125
Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol 125
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 124
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 124
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 120
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 119
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 119
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 118
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl) pyrrolidine sulfoxide derivatives 118
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 114
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 113
“Enantiomers of 8-(tert-butylamino-2-hydroxypropoxy) 3,4-dihydro-3-oxo-2H-(1,4) Benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity“. 108
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 106
5HT2B receptor antagonists: a probe for spotting the pharmacophore 106
Totale 15.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.760 0 0 444 855 244 403 372 413 297 269 159 304
2020/20213.890 208 357 256 300 259 362 632 95 320 189 556 356
2021/20221.978 190 476 39 103 101 66 100 154 143 231 144 231
2022/20232.329 257 120 84 382 262 312 13 147 390 121 171 70
2023/20241.780 250 103 112 59 70 119 88 103 200 71 67 538
2024/2025353 207 146 0 0 0 0 0 0 0 0 0 0
Totale 21.183